These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 37026259)

  • 41. sPLA
    Wei Y; Asbell PA
    Exp Eye Res; 2020 Dec; 201():108209. PubMed ID: 33011237
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Emerging therapies for dry eye disease.
    Mason L; Jafri S; Dortonne I; Sheppard JD
    Expert Opin Emerg Drugs; 2021 Dec; 26(4):401-413. PubMed ID: 34846978
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The core mechanism of dry eye disease is inflammation.
    Wei Y; Asbell PA
    Eye Contact Lens; 2014 Jul; 40(4):248-56. PubMed ID: 25390549
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dysregulated Tear Fluid Nociception-Associated Factors, Corneal Dendritic Cell Density, and Vitamin D Levels in Evaporative Dry Eye.
    Khamar P; Nair AP; Shetty R; Vaidya T; Subramani M; Ponnalagu M; Dhamodaran K; D'souza S; Ghosh A; Pahuja N; Deshmukh R; Ahuja P; Sainani K; Nuijts RMMA; Das D; Ghosh A; Sethu S
    Invest Ophthalmol Vis Sci; 2019 Jun; 60(7):2532-2542. PubMed ID: 31195410
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Investigational drugs in dry eye disease.
    Nebbioso M; Fameli V; Gharbiya M; Sacchetti M; Zicari AM; Lambiase A
    Expert Opin Investig Drugs; 2016 Dec; 25(12):1437-1446. PubMed ID: 27754718
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ion channels in dry eye disease.
    Ashok N; Khamar P; D'Souza S; Gijs M; Ghosh A; Sethu S; Shetty R
    Indian J Ophthalmol; 2023 Apr; 71(4):1215-1226. PubMed ID: 37026252
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Safety and efficacy of topical diquafosol for the treatment of dry eye disease: An updated meta-analysis of randomized controlled trials.
    Liu S; Yang G; Li Q; Tang S
    Indian J Ophthalmol; 2023 Apr; 71(4):1304-1315. PubMed ID: 37026262
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ocular surface immune cell diversity in dry eye disease.
    Nair AP; D'Souza S; Khamar P; Nuijts RMMA; Sethu S; Shetty R
    Indian J Ophthalmol; 2023 Apr; 71(4):1237-1247. PubMed ID: 37026254
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Matrix Metalloproteinase 9 Testing in Dry Eye Disease Using a Commercially Available Point-of-Care Immunoassay.
    Messmer EM; von Lindenfels V; Garbe A; Kampik A
    Ophthalmology; 2016 Nov; 123(11):2300-2308. PubMed ID: 27665213
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Topical corticosteroids for dry eye.
    Liu SH; Saldanha IJ; Abraham AG; Rittiphairoj T; Hauswirth S; Gregory D; Ifantides C; Li T
    Cochrane Database Syst Rev; 2022 Oct; 10(10):CD015070. PubMed ID: 36269562
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Correlations between tear cytokines, chemokines, and soluble receptors and clinical severity of dry eye disease.
    Na KS; Mok JW; Kim JY; Rho CR; Joo CK
    Invest Ophthalmol Vis Sci; 2012 Aug; 53(9):5443-50. PubMed ID: 22789923
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A Metabolome-Wide Study of Dry Eye Disease Reveals Serum Androgens as Biomarkers.
    Vehof J; Hysi PG; Hammond CJ
    Ophthalmology; 2017 Apr; 124(4):505-511. PubMed ID: 28139245
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Mucin-Deficient Ocular Surface Mimetic Platform for Interrogating Drug Effects on Biolubrication, Antiadhesion Properties, and Barrier Functionality.
    Madl AC; Liu C; Cirera-Salinas D; Fuller GG; Myung D
    ACS Appl Mater Interfaces; 2022 Apr; 14(16):18016-18030. PubMed ID: 35416028
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prolactin Inducible Protein, but Not Prolactin, Is Present in Human Tears, Is Involved in Tear Film Quality, and Influences Evaporative Dry Eye Disease.
    Jüngert K; Paulsen F; Jacobi C; Horwath-Winter J; Garreis F
    Front Med (Lausanne); 2022; 9():892831. PubMed ID: 35847789
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ocular allergy as a risk factor for dry eye in adults and children.
    Villani E; Rabbiolo G; Nucci P
    Curr Opin Allergy Clin Immunol; 2018 Oct; 18(5):398-403. PubMed ID: 30015640
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Conjunctivochalasis and Tear Osmolarity Are Associated With Reduced Conjunctival Epithelial Thickness in Dry Eye.
    Gumus K; Pflugfelder SC
    Am J Ophthalmol; 2021 Jul; 227():35-44. PubMed ID: 33571473
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dry Eye Disease: Early Recognition with Guidance on Management and Treatment for Primary Care Family Physicians.
    Verjee MA; Brissette AR; Starr CE
    Ophthalmol Ther; 2020 Dec; 9(4):877-888. PubMed ID: 33090327
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Relevance of Lipid-Based Products in the Management of Dry Eye Disease.
    Garrigue JS; Amrane M; Faure MO; Holopainen JM; Tong L
    J Ocul Pharmacol Ther; 2017 Nov; 33(9):647-661. PubMed ID: 28956698
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy and retention of silicone punctal plugs for treatment of dry eye in patients with and without ocular graft-versus-host-disease.
    Singh RB; Yung A; Coco G; Sinha S; Dohlman TH; Yin J; Dana R
    Ocul Surf; 2020 Oct; 18(4):731-735. PubMed ID: 32738300
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy of topical cyclosporine 0.05% and osmoprotective lubricating eye drops in treating dry eye disease and inflammation.
    Mullick R; Annavajjhala S; Thakur P; Mohapatra A; Shetty R; D'Souza S
    Indian J Ophthalmol; 2021 Dec; 69(12):3473-3477. PubMed ID: 34826977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.